Literature DB >> 8318467

Quantification of melanin and iron content in uveal malignant melanomas and correlation with magnetic resonance image.

J D Ferris1, P A Bloom, P R Goddard, C Collins.   

Abstract

Eleven patients with uveal malignant melanomas (MM) were studied by magnetic resonance (MR) imaging before enucleation. The MR appearances varied, but often were different from those previously reported to be characteristic of these tumours. Using an image analyser to assess quantitatively the melanin and iron content of each tumour, a wide range of tumour melanin concentrations was found, but universally low tumour iron concentrations. These values were compared with MR appearances that were quantified and expressed as contrast to noise ratios. The correlation between T1 and T2 shortening and increasing melanin content did not reach statistical significance. There was no correlation between MR appearances and iron content. The theories postulated to explain the diverse MR appearances of uveal MMs are discussed and variations in tumour melanin content and differences in scanner strengths are suggested as the most likely explanations.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8318467      PMCID: PMC504509          DOI: 10.1136/bjo.77.5.297

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  24 in total

1.  Surface-coil MR imaging of orbital neoplasms.

Authors:  J A Sullivan; S E Harms
Journal:  AJNR Am J Neuroradiol       Date:  1986 Jan-Feb       Impact factor: 3.825

2.  Lesions simulating malignant melanoma of the posterior uvea.

Authors:  J A Shields
Journal:  Arch Ophthalmol       Date:  1973-06

3.  Human tumors by NMR.

Authors:  R Damadian; K Zaner; D Hor; T Dimaio
Journal:  Physiol Chem Phys       Date:  1973

4.  Radicals in melanin biochemistry.

Authors:  R C Sealy
Journal:  Methods Enzymol       Date:  1984       Impact factor: 1.600

Review 5.  Uveal melanoma and similar lesions: the role of magnetic resonance imaging and computed tomography.

Authors:  G A Peyman; M F Mafee
Journal:  Radiol Clin North Am       Date:  1987-05       Impact factor: 2.303

6.  Choroidal melanomas: correlation of NMR spectroscopy and MR imaging.

Authors:  J M Gomori; R I Grossman; J A Shields; J J Augsburger; P M Joseph; D DeSimeone
Journal:  Radiology       Date:  1986-02       Impact factor: 11.105

7.  Intrachoroidal hemorrhage mistaken for malignant melanoma.

Authors:  J A Mauriello; L E Zimmerman; T B Rothstein
Journal:  Ann Ophthalmol       Date:  1983-03

8.  Magnetic resonance imaging in the evaluation and differentiation of uveal melanoma.

Authors:  M F Mafee; G A Peyman; J H Peace; S B Cohen; M W Mitchell
Journal:  Ophthalmology       Date:  1987-04       Impact factor: 12.079

9.  Errors in the diagnosis of malignant melanoma of the choroid.

Authors:  D M Robertson; R J Campbell
Journal:  Am J Ophthalmol       Date:  1979-03       Impact factor: 5.258

10.  Retinoblastoma and simulating lesions: role of CT and MR imaging.

Authors:  M F Mafee; M F Goldberg; M J Greenwald; J Schulman; A Malmed; A E Flanders
Journal:  Radiol Clin North Am       Date:  1987-07       Impact factor: 2.303

View more
  3 in total

1.  Primary clear cell sarcoma of the sacrum: a case report.

Authors:  Weibin Zhang; Yuhui Shen; Rong Wan; YanBo Zhu
Journal:  Skeletal Radiol       Date:  2010-12-23       Impact factor: 2.199

2.  Diffusion-weighted MRI for uveal melanoma liver metastasis detection.

Authors:  Mathilde Wagner; Pascale Mariani; François Clément Bidard; Manuel Jorge Rodrigues; Fereshteh Farkhondeh; Nathalie Cassoux; Sophie Piperno-Neumann; Slavomir Petras; Vincent Servois
Journal:  Eur Radiol       Date:  2015-02-26       Impact factor: 5.315

3.  Single shot echo planar imaging (ssEPI) vs single shot turbo spin echo (ssTSE) DWI of the orbit in patients with ocular melanoma.

Authors:  Ekim Gumeler; Safak Parlak; Gozde Yazici; Erdem Karabulut; Hayyam Kiratli; Kader K Oguz
Journal:  Br J Radiol       Date:  2020-12-22       Impact factor: 3.039

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.